Everyday Health on MSN4h
Cancer and Multiple Sclerosis: A Mixed Story
A cancer diagnosis has hit very close to home in recent months. It’s likely that cancer has also struck close to most of ...
Knowridge Science Report10h
High-dose vitamin D may help slow early multiple sclerosis
A new study from researchers in France has found that taking high doses of vitamin D every two weeks may help reduce disease ...
Campaign Middle East on MSN14h
NMSS’ Move for MS campaign uses Snap AR to shed light on multiple sclerosis
In line with MS Awareness Month, the National Multiple Sclerosis Society (NMSS) in collaboration with Snap, has launched its ...
Pharmabiz2d
US FDA accepts for priority review Sanofi’s regulatory submission of tolebrutinib for patients with multiple sclerosis
US FDA accepts for priority review Sanofi’s regulatory submission of tolebrutinib for patients with multiple sclerosis: Paris Wednesday, March 26, 2025, 09:00 Hrs [IST] The US F ...
Applied Clinical Trials Online3d
Results of Phase III HERCULES, GEMINI 1 and 2 Trials Lead to FDA Priority Review for Tolebrutinib for Non-Relapsing Secondary Progressive MS
FDA grants Priority Review status to Sanofi's tolebrutinib for the treatment of non-relapsing secondary progressive multiple ...
PharmiWeb3d
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) and to ...
Sanofi: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only brain-penetrant BTK inhibitor to ...
MedPage Today4d
Deciding Whether Multiple Sclerosis Treatment Should Be Discontinued
Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...
Everyone thought I was tired, turns out I had a brain disease
Multiple sclerosis (MS) is a condition that affects the brain and spinal cord. Some of the most common symptoms include ...
Medscape8d
Can Central Vein Sign Distinguish Multiple Sclerosis From Its Most Common Mimic?
Using 3T MRI to analyze central vein counts and distribution in white matter lesions allows investigators to distinguish ...
Physician's Weekly9d
Benefits of HSCT in MS Should Be Weighed Against Impact on Cognition
Research showed that HSCT in MS was associated with long-term improvements in quality of life but may cause short-term cognitive decline post-treatment.